Paper Details

  1. Home
  2. Paper Details

2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis.

Author: AudranMaurice, BlainHubert, BreuilVéronique, BriotKarine, ChapuisLaure, ChapurlatRoland, CortetBernard, FardellonePatrice, FeronJean-Marc, GauvainJean-Bernard, GuggenbuhlPascal, KoltaSami, LespessaillesEric, LetombeBrigitte, MarcelliChristian, OrcelPhilippe, RouxChristian, SeretPatrick, ThomasThierry, TrémollièresFlorence

Consensus Development ConferenceA conference organized by the National Institutes of Health (NIH) to develop consensus and recommendations on medical issues.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

The French National Authority for Health updated their 2006 evidence-based position statement on pharmacological treatments for postmenopausal osteoporosis. The updated statement was created with input from several learned societies in France.
Paper Details　
Original Abstract of the Article :
To update the evidence-based position statement published by the French National Authority for Health (HAS) in 2006 regarding the pharmacological treatment of postmenopausal osteoporosis, under the auspices of the French Society for Rheumatology and Groupe de Recherche et d'Information sur les Ostéo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.jbspin.2012.02.014

データ提供：米国国立医学図書館（NLM）

French Guidelines for Postmenopausal Osteoporosis Treatment: A 2012 Update

The field of [Osteoporosis] is constantly evolving, with new research and clinical guidelines emerging regularly. This study presents the updated French guidelines for the pharmacological treatment of [Postmenopausal Osteoporosis], a condition that affects millions of women worldwide. These guidelines, developed by a consortium of leading medical societies, provide evidence-based recommendations for managing this debilitating condition.

Navigating the Landscape of Osteoporosis Treatment

The updated French guidelines offer a comprehensive approach to [Postmenopausal Osteoporosis] management, providing recommendations based on the latest scientific evidence. These guidelines serve as a valuable tool for healthcare providers, ensuring that patients receive the most effective and appropriate treatment options. It's like having a map for the desert of [Osteoporosis], guiding us towards the best path for optimal health.

Improving Osteoporosis Care with Updated Guidelines

This research emphasizes the importance of staying abreast of the latest developments in [Osteoporosis] management. Regularly updated guidelines, like the ones presented in this study, are crucial for ensuring high-quality care for patients. It's like having a compass that constantly adjusts to the changing landscape of medical knowledge.

Dr.Camel's Conclusion

The desert of [Osteoporosis] can be a daunting place, but these updated guidelines offer a roadmap to better health. They serve as a reminder that knowledge is essential for navigating the complexities of this condition and ensuring the best possible care for patients. It's like having a trusty camel guide, leading us through the desert with expertise and compassion.

Date :
  1. Date Completed 2012-09-04
  2. Date Revised 2022-03-18
Further Info :

Pubmed ID

22521109

DOI: Digital Object Identifier

10.1016/j.jbspin.2012.02.014

Related Literature

Article Analysis
・Effective treatment of osteoporosis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.